Allianz Asset Management GmbH - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 59 filers reported holding PROQR THRAPEUTICS N V in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q1 2020$134,000
-85.9%
24,400
-74.6%
0.00%
-100.0%
Q4 2019$953,000
+426.5%
96,070
+208.7%
0.00%
Q3 2019$181,000
-48.6%
31,125
-19.4%
0.00%
Q2 2019$352,000
-39.7%
38,625
-8.4%
0.00%
-100.0%
Q1 2019$584,000
-4.7%
42,145
+8.0%
0.00%0.0%
Q4 2018$613,00039,0100.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2018
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 2,401,570$14,602,0002.94%
DAFNA Capital Management LLC 1,237,400$7,523,0002.17%
RTW INVESTMENTS, LP 4,902,785$29,809,0000.84%
Kerrisdale Advisers, LLC 453,182$2,755,0000.31%
COWEN AND COMPANY, LLC 300,042$1,824,0000.30%
Artal Group S.A. 1,259,177$7,656,0000.21%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$27,664,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 221,360$1,346,0000.06%
FRANKLIN STREET ADVISORS INC /NC 60,000$365,0000.04%
JENNISON ASSOCIATES LLC 2,625,514$15,963,0000.01%
View complete list of PROQR THRAPEUTICS N V shareholders